BRIEF-Kleo Pharmaceuticals appoints David A. Spiegel as CEO

Thu Sep 22, 2016 10:42am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Sept 22 (Reuters) - Portage Biotech Inc

* Kleo Pharmaceuticals Inc. appoints David A. Spiegel as chief executive officer

* Says Spiegel will also serve on company's Board of directors Source text for Eikon: Further company coverage: